The Research and Development team at Kurome Therapeutics is responsible for advancing innovative cancer therapies that disrupt immune evasion mechanisms in tumor cells. This interdisciplinary group collaborates on experimental design, translational studies, and pharmacological evaluations to bring novel treatments from the lab to clinical trials, ensuring that promising therapies effectively target resistant cancer cells.
View all